High Times
Home > Boards > US OTC > Biotechs > Vivos Inc. (RDGL)

Go to as many TV news website contact

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (5) | Next 10 | Previous | Next
dcsteve Member Profile
Member Level 
Followed By 532
Posts 27,030
Boards Moderated 1
Alias Born 12/30/11
160x600 placeholder
Withdrawal of Registration Statement (rw) Edgar (US Regulatory) - 10/5/2018 5:00:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2018 6:11:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/21/2018 5:04:41 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/17/2018 4:47:23 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/20/2018 6:19:29 AM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/14/2018 4:47:26 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/18/2018 6:07:38 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 7/5/2018 2:54:23 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/22/2018 12:10:22 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2018 2:39:19 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/2/2018 3:57:41 PM
Vivos Adds Commercial Expertise to its Veterinary Medicine Advisory Board GlobeNewswire Inc. - 3/20/2018 9:30:00 AM
Vivos Receives FDA Confirmation of RadioGel Device Classification for Animal Skin Cancer Therapy GlobeNewswire Inc. - 1/30/2018 9:00:00 AM
Vivos Completes Planned Dosing Schedule for Feline Sarcoma Program GlobeNewswire Inc. - 1/12/2018 2:20:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2017 5:28:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/21/2017 1:41:31 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2017 6:24:22 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (5) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist